ARAY - Accuray Incorporated
| Previous close | 2.8400 |
| Open | 2.8200 |
| Bid | 2.5000 x 3200 |
| Ask | 3.0500 x 3000 |
| Day's range | 2.7750 - 2.8600 |
| 52-week range | 2.3500 - 5.4000 |
| Volume | 383,551 |
| Avg. volume | 482,187 |
| Market cap | 250M |
| Beta (5Y Monthly) | 2.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1880 |
| Earnings date | 20 Jan 2020 - 24 Jan 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.88 |
- Zacks
Accuray (ARAY) Up 10.9% Since Last Earnings Report: Can It Continue?
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Intuitive Surgical (ISRG) Boosts da Vinci System With FDA Nod
Intuitive Surgical (ISRG) is likely to strengthen its da Vinci surgical system with the recent FDA nod.
- Simply Wall St.
Is Accuray Incorporated (NASDAQ:ARAY) Trading At A 30% Discount?
In this article we are going to estimate the intrinsic value of Accuray Incorporated (NASDAQ:ARAY) by estimating the...
- Zacks
Accuray (ARAY) Q1 Wider Than Expected, FY20 View Retained
Accuray (ARAY) reiterates revenue and adjusted EBITDA view for fiscal 2020.
- Zacks
Accuray (ARAY) Reports Q1 Loss, Lags Revenue Estimates
Accuray (ARAY) delivered earnings and revenue surprises of -10.00% and -4.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Accuray (NASDAQ:ARAY) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
- Zacks
AngioDynamics Boosts VIT Product Portfolio With New Buyout
AngioDynamics (ANGO) is likely to see an expansion of its already existing VIT product portfolio with the buyout of Eximo Medical.
- Zacks
Luminex Gets FDA Nod for ARIES MRSA Assay, Boosts Platform
Luminex (LMNX) receives FDA clearance for the ARIES MRSA assay, which is likely to provide a boost to the company's ARIES platform.
- Simply Wall St.
Is It Time To Consider Buying Accuray Incorporated (NASDAQ:ARAY)?
Accuray Incorporated (NASDAQ:ARAY), which is in the medical equipment business, and is based in United States, saw a...
- Zacks
The Rise of Robots in Surgery Puts Spotlight on These 3 Stocks
A number of MedTech companies are currently attempting to gain ground within the robotics-aided healthcare market.
- Zacks
Accuray's (ARAY) CyberKnife Delivers Improved Patient Outcome
Accuray's (ARAY) CyberKnife delivers stereotactic body radiation therapy in only five sessions.
- Zacks
Why Is Accuray (ARAY) Down 1% Since Last Earnings Report?
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Here's Why Investors Should Retain Accuray (ARAY) Stock Now
Accuray (ARAY) slashes fiscal 2020 revenue guidance owing to tariffs in China.
- Simply Wall St.
Have Insiders Been Selling Accuray Incorporated (NASDAQ:ARAY) Shares?
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
- Motley Fool
Here's Why Accuray Stock Is Nosediving Today
Disappointing fourth-quarter results are taking a toll on the medical device stock.
- Zacks
Accuray (ARAY) Reports Loss in Q4, Revenues Beat Estimates
Accuray (ARAY) expects fiscal 2020 revenues to be impacted by China tariffs.
- Motley Fool
No Hooray for Accuray in Q4
The CyberKnife maker missed Wall Street bottom-line estimates and announced disappointing guidance for fiscal 2020.
Motley FoolAccuray Inc (ARAY) Q4 2019 Earnings Call Transcript
ARAY earnings call for the period ending June 30, 2019.
- Zacks
Accuray (ARAY) Reports Q4 Loss, Tops Revenue Estimates
Accuray (ARAY) delivered earnings and revenue surprises of -166.67% and 1.14%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Does Accuray Incorporated's (NASDAQ:ARAY) CEO Salary Compare Well With Others?
In 2012 Joshua Levine was appointed CEO of Accuray Incorporated (NASDAQ:ARAY). First, this article will compare CEO...
- Zacks
Accuray (ARAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Accuray (ARAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
How Does Investing In Accuray Incorporated (NASDAQ:ARAY) Impact The Volatility Of Your Portfolio?
If you're interested in Accuray Incorporated (NASDAQ:ARAY), then you might want to consider its beta (a measure of...
- Simply Wall St.
How Many Accuray Incorporated (NASDAQ:ARAY) Shares Do Institutions Own?
Every investor in Accuray Incorporated (NASDAQ:ARAY) should be aware of the most powerful shareholder groups...
- Zacks
AngioDynamics Divests NAMIC Portfolio to Medline Industries
The NAMIC fluid management portfolio sale clears all of AngioDynamics' (ANGO) outstanding debt.
- Simply Wall St.
Volatility 101: Should Accuray (NASDAQ:ARAY) Shares Have Dropped 47%?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The main aim of stock picking is to find the market-beating stocks. But every investor is virtua...
